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ABSTRACT
Spaceflight induces pathophysiological alterations in various organs. To study 
pathophysiological adaptations to weightlessness on the ground, the tail suspension 
(TS) rat model has been used to simulate the effects of weightlessness. There is 
currently little information on the effect of TS on the expression and activity of nitric 
oxide synthase (NOS) in the brain. In this study, we examined time-dependent 
alterations in the expression and activity of neuronal NOS (nNOS) in the brains of 
TS rats. Male Sprague-Dawley rats were tail-suspended for 1 (TS1), 7 (TS7), and 14 
(TS14) days or rested on the ground for 3 days after 14 days of TS. TS1 and TS7 rats 
exhibited no significant alterations in the expression of nNOS compared to control 
rats, whereas nNOS expression in TS14 rats was significantly upregulated compared 
to control rats. Normalized expression of nNOS mRNA and protein in TS14 rats (1.86 
± 0.48 and 1.84 ± 0.29, respectively) were significantly higher than that of control 
rats (P < 0.001 and P < 0.001, respectively). Consistent with these results, significant 
elevations in NOS activity and NO production were observed in TS14 rats. Thus, 
we demonstrated a significant upregulation of nNOS expression, accompanied by 
significant increases in NOS activity and NO production, in the brain of rats exposed 
to simulated weightlessness.
INTRODUCTION
The success of space missions over the past 50 
years has highlighted the necessity and advantages of 
human space exploration. However, as human space 
travel becomes more feasible in the 21st century, the 
health and safety of space travelers have become the 
most important concern. Because experiments performed 
in space are both demanding and expensive, several 
experimental models have been developed to simulate 
weightlessness/microgravity. Gravity is an essential force 
that influences many physiological functions. Indeed, 
changes in gravitational force affect many aspects of 
human pathophysiology [1]. For example, exposure to 
weightlessness such as that experienced by astronauts 
during spaceflight induces a redistribution of blood and 
body fluid from the caudad to cephalad portion of the body 
and eliminates the cephalocaudal hydrostatic pressure 
gradient [2]. This redistribution involves approximately 
2,000 mL of blood and body fluid, leading to the so-
called puffy faces and bird legs described by astronauts. 
In addition, astronauts frequently experience symptoms of 
headache and stuffiness in the nose and throat [1]. Some of 
these symptoms are thought to be related to changes in the 
cerebrospinal fluid volume and may be due to adaptation 
[3].
The tail suspension (TS) rat model has been used to 
investigate weightlessness-induced alterations including 
the redistribution of body fluid and volume changes in 
cerebrospinal fluid. The TS rat model was first introduced 
by Morey-Holton and was later improved by Morey-
Holton and Globus [4]. The TS rat model induces a 
cephalic fluid shift and postural muscle unloading, which 
are characteristics of exposure to weightlessness [5, 6]. 
In addition, TS rats exhibit specific adaptations similar 
to those seen in astronauts during spaceflight, including 
postural muscle atrophy, hypovolemia, a diminished 
capacity for elevated vascular resistance, orthostatic 
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hypotension, and reduced aerobic capacity [7]. Moreover, 
if prolonged for several days, the fluid shift that develops 
in TS rats alters the expression of certain genes and 
proteins [8].
Nitric oxide (NO) is an endogenous modulator 
produced by various types of cells in different tissues 
and regulates numerous biological processes [9]. NO 
is the most potent endogenous vasodilator and plays an 
important role in the regulation of systemic vascular 
resistance and tissue perfusion. In addition, NO inhibits 
renal tubular sodium reabsorption and contributes to 
sodium and extracellular fluid volume homeostasis [9-
13]. Through these mechanisms, NO plays a crucial 
role in the regulation of blood pressure. Neuronal NO 
synthase (nNOS), a calcium-dependent isoform of NOS, 
is constitutively expressed in neuronal cells. nNOS can 
produce NO by converting L-arginine to L-citrulline in the 
presence of nicotinamide adenine dinucleotide phosphate 
(NADPH), oxygen, and other co-factors [14, 15]. Previous 
studies have shown that TS increases vascular NO activity 
and NOS expression in the aorta, heart, and kidneys [9, 
16], suggesting that simulated weightlessness alters the 
expression and activity of NOS. Moreover, a few studies 
have documented the association between simulated 
weightlessness and alteration in nNOS expression or 
activity [9, 17]; however, there is little information about 
the effects of simulated weightlessness on the expression 
and activity of nNOS in the brain. Thus, in the present 
study, we examined the time-dependent alteration in nNOS 
expression and activity in the brain tissues of control and 
TS rats, an animal model of simulated weightlessness.
RESULTS
A schematic of our experimental design is shown 
in Figure 1. Quantitative analysis of nNOS mRNA 
expression in brain tissue revealed a significant increase 
in TS14 rats compared to control rats (P < 0.001), 
which remained significantly high until 3 days post-
suspension (TS14+3; P = 0.002). The maximal mRNA 
expression of nNOS was observed for the TS14 rats, and 
the increase in nNOS appeared as single peak, with TS1 
and TS7 rats exhibiting a slight increase in nNOS mRNA 
level compared to control rats, but the differences were 
not statistically significant (P = 1.000 and P = 0.263, 
respectively). Consistent with the mRNA data, nNOS 
protein levels on Western  blot analysis were significantly 
higher in the TS14 and TS14+3 rats than in the control rats 
(P < 0.001 and P < 0.001, respectively), while the protein 
expression of nNOS in the TS1 and TS7 rats was not 
significantly different from that of control rats (P = 1.000 
and P = 1.000, respectively). The mRNA and protein 
expression levels of TS14+3 rats were slightly decreased 
compared to those of the TS14 rats, but the difference 
between the two groups was not statistically significant 
(P = 0.945 and P = 1.000, respectively). The mean nNOS 
expression compared between groups is shown in Table 1.
We next measured the conversion of [14C]-labeled 
L-arginine to L-citrulline in brain tissues to quantify NOS 
activity. Our results revealed a concordance between NOS 
activity and expression: NOS activity was significantly 
elevated in the TS14 rats (P < 0.001), and this elevation 
persisted until 3 days post-suspension (TS14+3; P < 
0.001). Similar to the pattern of mRNA and protein 
expression, the enzymatic activity of TS1 and TS7 rats 
revealed an increasing trend compared to the control rats, 
but the differences were not statistically significant (P = 
0.238 and P = 0.128, respectively). The means of NOS 
activity for each group is shown in Table 2.
Level of nitrate plus nitrite in the brain exhibited 
a trend similar to that of NOS activity and expression. 
Specifically, nitrate plus nitrite levels were significantly 
elevated in TS14 rats (P < 0.001), remained significantly 
high through 3 days post-suspension (TS14+3; P < 0.001), 
and the difference in levels between the two groups was 
not statistically significant (P = 0.140). Lastly, the TS1 
and TS7 rats exhibited similar NO production to that of 
the control rats (P = 1.000 and P = 1.000, respectively). 
The mean level of nitrate plus nitrite level for each group 
is shown in Table 2.
Previous studies stated that TS does not appear to be 
stressful to animals, as assessed by corticosterone level, 
weights of adrenal glands and thymus, and total body 
weight [18, 19]. In those studies, food and water intake, 
grooming, defecation, and urination behavior were used 
Figure 1: Scheme of the experimental design. The experimental groups were exposed to simulated weightlessness by tail suspension 
(TS) for 1 (TS1), 7 (TS7), or 14 (TS14) days or rested on the ground for 3 days after 14 days of TS (TS14+3). The number of rats per group 
was 8.
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as indications that the rats were not under overt stress. In 
addition, the animals that exhibited excessive weight loss 
(more than 10%) or overt signs of stress were removed 
from the study [20]. In the present study, no rats showed 
weight loss. We observed that the TS rats had higher body 
weights than the control rats (Figure 2), although there 
were no significant differences in body weight between the 
controls (201.11 ± 1.36 g) and the rats in the TS1 (202.39 
± 1.37 g; P = 1.000), TS7 (204.76 ± 1.52 g; P = 0.928), 
TS14 (205.71 ± 1.64 g; P = 0.362), or TS14+3 (206.34 
± 1.55 g; P = 0.184). Thus, on the basis of the above-
mentioned criteria, we considered that the TS model 
employed in the present study did not induce overt chronic 
stress.
Table 2: Effects of simulated weightlessness by tail suspension on nitric oxide synthase activity nitric oxide production
Group NOS activity (pM/mol/mg) Nitrate plus nitrite level (µM/mg)Mean ± SEM P value vs Control Mean ± SEM P value vs Control
Control 0.08 ± 0.04 12.03 ± 3.26
TS1 0.12 ± 0.02 0.238 12.35 ± 4.81 1.000
TS7 0.13 ± 0.02 0.128 15.58 ± 1.91 1.000
TS14 0.26 ± 0.04 < 0.001 30.60 ± 7.35 < 0.001
TS14+3 0.17 ± 0.05 < 0.001 23.59 ± 7.45 0.001
Figure 2: Effects of simulated weightlessness by tail suspension on body weight. Box and whisker diagram. The band inside 
each box is the median value of the indicated group. Body weight exhibited an increasing trend during the observation period, but the 
differences among groups were not statistically significant.
Table 1: Effects of simulated weightlessness by tail suspension on neuronal nitric oxide synthase expression
Group Normalized mRNA expression ratio Normalized protein expression ratioMean ± SEM P value vs Control Mean ± SEM P value vs Control
Control 1.00 1.00
TS1 1.23 ± 0.20 1.000 1.15 ± 0.23 1.000
TS7 1.34 ± 0.20 0.263 1.18 ± 0.15 1.000
TS14 1.86 ± 0.48 < 0.001 1.84 ± 0.29 < 0.001
TS14+3 1.61 ± 0.34 0.002 1.71 ± 0.29 < 0.001
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DISCUSSION
There have been relatively few studies on the effects 
of simulated weightlessness on the brain. A study using 
cDNA microarrays showed that TS induces considerable 
transcriptomic alterations in several functional pathways 
including those involving blood coagulation, immune 
responses, and ion channels [1]. Proteomic analysis in the 
hippocampus of TS mice revealed changes in structural 
proteins coupled with the loss of proteins involved in 
cellular metabolism [21]. A similar analysis performed 
in the hypothalamus revealed alteration in biomarkers 
of oxidative stress, indicating vulnerability of the 
hypothalamus to the stress generated by weightlessness 
[22]. Taken together, these studies suggest that exposure 
to weightlessness affects several aspects of brain function. 
Meanwhile, there have been only two studies to date that 
have investigated the effects of simulated weightlessness 
on the expression of nNOS in the brain. Mueller et al. 
[17] showed a higher nNOS protein expression in the 
paraventricular and supraoptic nuclei of the hypothalamus 
of rats subjected to TS for 14 days. Similarly, Vaziri et 
al. [9] observed a significant elevation of nNOS protein 
expression in the brains of rats exposed to simulated 
weightlessness by TS for 20 days. Taken together, 
these data suggest that increased nNOS in the brain 
is involved in the regulation of vasodilatory tone and 
central sympathetic outflow and contributes to autonomic 
and humoral alterations following cardiovascular 
deconditioning.
Consistent with previous data, the TS rats employed 
in this study exhibited a significant upregulation of 
brain nNOS expression and activity. nNOS is normally 
expressed in various regions of the brain and is thought 
to be involved in neurogenic control of blood pressure 
by inhibiting central sympathetic outflow [9, 23-
25]. Consequently, nNOS-derived NO in the brain is 
considered to exert a blood pressure-lowering influence. 
Our observations raise the possibility that upregulation 
of brain nNOS may contribute to orthostatic intolerance 
by suppressing central sympathetic outflow following 
exposure to weightlessness. In support of this notion, 
Moffitt et al. [26] reported a marked attenuation of 
sympathetic nerve activity in TS rats compared to control 
rats. Moreover, previous studies using several animal 
models of hypertension have demonstrated that NOS-
derived NO modulates sympathetic nervous activity. Ye 
et al. [27] observed that treatment with L-arginine, the 
substrate of NOS, attenuates the severity of hypertension 
in rats with chronic renal failure, whereas treatment with 
L-NG-nitroarginine methyl ester (L-NAME), a competitive 
inhibitor of NOS, causes accelerated hypertension. In that 
study, the authors also noted a dose-response relationship 
between the amount of L-NAME ingested and the severity 
of hypertension as well as a positive relationship between 
NOS expression and norepinephrine turnover rate after 
treatment with L-NG-nitroarginine methyl ester, suggesting 
that endogenous NO inhibits sympathetic nervous activity 
in the brain and is involved in the neurogenic inhibitory 
regulation of blood pressure. Ni et al. [28] observed 
Figure 3: Effects of simulated weightlessness by tail suspension (TS) on neuronal nitric oxide synthase (nNOS) 
expression. A. nNOS mRNA expression was significantly elevated at 14 days of TS (P < 0.001) and remained significantly high after 3 
days post-suspension (P = 0.002). B. Significantly elevated nNOS protein levels were observed in the TS14 (P < 0.001) and TS14+3 (P 
< 0.001) rats. The expression levels of both mRNA and protein were slightly decreased in the TS14+3 rats compared to those in the TS14 
rats, but the differences between the two groups were not statistically significant.
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that a high-salt diet upregulated nNOS expression in the 
brain, suggesting the involvement of NOS in the control 
of blood pressure. These data also suggest a possible 
role of elevated blood pressure in the regulation of brain 
nNOS expression. A previous study showed that shifts 
in gravitational force markedly raised intracranial blood 
pressure, although TS rats did not develop systemic 
hypertension [5, 29]. This local rise in blood pressure 
in the cerebral circulation may be responsible for the 
observed upregulation of brain nNOS expression in TS 
rats.
Although quantitative real-time reverse 
transcriptase-polymerase chain reaction (RT-PCR) 
and Western blot analysis demonstrated a significant 
upregulation in nNOS expression in the given tissues, 
it did not identify the specific regions or cell types that 
contributed to this phenomenon. However, based on 
previous observations by Mueller et al. [17], the source of 
increased nNOS expression in the brain of TS rats appears 
to be the hypothalamus, especially the paraventricular and 
supraoptic nuclei. Immunohistochemical localization of 
nNOS in sequential brain tissue samples obtained from 
TS rats will be necessary to confirm the time-dependent 
alteration in nNOS expression observed in this study.
In conclusion, exposure of rats to simulated 
weightlessness in the TS model resulted in a significant 
increase in brain nNOS expression. This upregulation of 
nNOS expression in TS rats was coupled with significant 
increases in NOS activity and NO production. Our 
observations raise the possibility that upregulation of 
brain nNOS may contribute to orthostatic intolerance 
by suppressing central sympathetic outflow following 
exposure to weightlessness.
MATERIALS AND METHODS
Tail suspension rat model
This study used male Sprague-Dawley rats eight 
weeks of age and weighing 190‒210 g. Rats were fed 
standard laboratory rat chow, provided free access to water, 
and were maintained on a 12-hour light/dark cycle under 
temperature and moisture levels controlled at 20‒25°C and 
40‒45%, respectively. To avoid any effect of unfavorable 
factors including fear and stress, the rats were acclimatized 
to the rearing environment for 7 days before the beginning 
of experiments. Animals were randomly assigned to one 
of four experimental groups or one control group. Rats in 
the experimental groups were tail-suspended for 1 (TS1; 
n=8), 7 (TS7; n=8), or 14 (TS14; n=8) days or rested 
on the ground for 3 days after 14 days of TS (TS14+3; 
n=8). The TS rat model was established as described 
previously [30, 31]. Briefly, the rats underwent an 
acclimation period during which they were tail-suspended 
for short durations (3 days; 1–3 hours per day) by either 
tail harness or stainless steel rings. For suspension, the 
tail was cleaned and dried, and adhesive sponge tape 
strips were adhered laterally along the two sides of the 
Figure 4: Effects of simulated weightlessness by tail suspension (TS) on nitric oxide synthase (NOS) activity and 
nitric oxide (NO) production. Data are presented as box and whisker diagrams, and the band inside each box is the median value of 
the indicated group. An L-[14C]-citrulline assay and a nitrate plus nitrite assay revealed similar trends with respect to the levels of NOS 
enzymatic activity and NO production, both of which were significantly increased after 14 days of TS. A. NOS activity was significantly 
upregulated in TS14 (P < 0.001) and TS14+3 (P < 0.001) rats. B. The maximal nitrate plus nitrite level was observed after 14 days of TS. 
The time-dependent alteration pattern was consistent with that of NOS expression and activity.
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proximal two-thirds of the tail. These longitudinal strips 
were then secured to the tail by three 1-cm-wide tape 
strips wrapped circumferentially at three sites along the 
length of the tail. To facilitate free movement about the 
cage, the cast was attached to a swivel anchored to the 
cage top, allowing a 360° range of movement. The rats 
were caged individually and maintained in a head-down 
tilt position of approximately 30°, with their hindlimbs 
unloaded. The control rats (n=8) in individual cages were 
treated identically except for the TS. During TS, the angle 
of suspension was re-adjusted as body size increased to 
prevent weight bearing on the hindlimbs. Because the TS 
rats had limited movement, they were groomed daily to 
prevent complications such as urine scald and infection. 
Daily health checks were performed to confirm that the 
exposed tip of the tail remained pink, which was taken as 
a sign of adequate blood flow.
After the TS period, rats were anesthetized with 
100% carbon dioxide for 90 seconds. The whole brain 
was removed, cleaned in phosphate buffered saline, 
snap frozen in liquid nitrogen, and stored at –70°C 
until processed. All experiments were approved by the 
Institutional Animal Care and Use Committee of the 
Republic of Korea Air Force Aerospace Medical Center 
(Cheongju, Chungcheongbuk-do, Republic of Korea). 
All experimental procedures involving animals were 
conducted in accordance with the Guide for Care and Use 
of Laboratory Animals published by the National Institutes 
of Health and the ethical guidelines of the International 
Association for the Study of Pain.
Quantitative real-time reverse transcriptase-
polymerase chain reaction analysis
Total RNA was isolated using the NucleoSpin RNA 
II extraction kit (Macherey-Nagel GmbH & Co. KG, 
Dueren, Germany) and used for cDNA synthesis with a 
ReverTra Ace-α- reverse transcriptase kit (Toyobo Co., 
Ltd., Osaka, Japan); both kits were used according to the 
manufacturers’ instructions. The amount of cDNA was 
determined photometrically. RT-PCR was performed 
using cDNA and a SsoAdvanced SYBR Green Supermix 
(Bio-Rad Laboratories, Inc., Hercules, CA, USA). PCR 
was performed using a Bio-Rad CFX96 Real-Time PCR 
Detection System (Bio-Rad Laboratories, Inc.) with a 
C1000 Thermal Cycler (Bio-Rad Laboratories, Inc.). 
PCR reactions for nNOS and glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH) were initiated with a denaturing 
step at 95°C for 3 minutes, followed by 40 cycles at 95°C 
for 10 seconds, 58°C for 10 seconds, and 72°C for 20 
seconds. A melting curve (ramping from 65–95°C) was 
performed following RT-PCR to test for the presence of 
primer dimers. The primer sequences for nNOS were 5′-
GGC ACT GGC ATC GCA CCC TT-3′ (sense) and 5′-
CTT TGG CCT GTC CGG TTC CC-3′ (antisense). The 
primer sequences for GAPDH were 5′-CAA GAA GGT 
GGT GAA GCA-3′ (sense) and 5′-GGT GGA GAG TGG 
GAG TT-3′ (antisense). In cases where a primer dimer 
was detected, PCR was repeated using a separate cDNA 
aliquot. Each measurement was repeated three times, and 
the values were used to calculate the ratio of nNOS to 
GAPDH, with the control set at a value of 1.0 to serve as 
a standard.
Western blot analysis
Tissue samples were homogenized in lysis 
buffer (50 mM Tris, pH 7.5, 1% Nonidet P-40, 2 mM 
ethylenediaminetetraacetic acid, 10 mM sodium chloride, 
20 μg/mL aprotinin, 20 μg/mL leupeptin, and 1 mM 
phenylmethylsulfonyl fluoride) at a volume of 1 mL 
per 100 mg tissue and placed on ice for 20 min. After 
centrifugation at 13,000 rpm for 20 min, the supernatant 
was collected and used for immunoblotting [32, 33]. 
Immunoblots were incubated with anti-nNOS antibody 
(1:500; Novus Biologicals, LLC, Littleton, CO, USA) or 
anti-GAPDH antibody (1:800; Novus Biologicals, LLC), 
followed by incubation with horseradish peroxidase-
conjugated secondary antibody (Cell Signaling 
Technology, Beverly, MA, USA). Protein bands were 
visualized using an enhanced chemiluminescence 
reagent (Amersham Biosciences, Buckinghamshire, UK) 
according to the manufacturer’s instructions.
Measurement of nitric oxide synthase activity 
with the L-[14C]-citrulline formation assay
Tissue samples were ground to a fine powder in 
liquid nitrogen and homogenized in a solution containing 
10 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic 
acid (pH 7.2), 0.32 M sucrose, 0.1 mM 
ethylenediaminetetraacetic acid, 1 mM dithiothreitol, 
and protease inhibitors (10 μg/mL each of leupeptin, 
pepstatin A, chymostatin, antipain, and soybean trypsin 
inhibitor and 100 μg/mL phenylmethylsulfonyl fluoride) 
[32, 33]. To differentiate calcium-dependent NOS activity 
from calcium-independent NOS activity, homogenates 
were centrifuged, and the supernatants were incubated at 
37°C for 60 min with one of the following mixtures: (1) 
assay cocktail: 2 μM L-[14C]-arginine (General Electric 
Healthcare, Milwaukee, WI, USA), 18 μM L-arginine, 1 
mM L-citrulline, 50 mM L-valine, 1 mM dithiothreitol, 
0.1 mM NADPH, 0.1 mM tetrahydrobiopterin, 1 mM 
magnesium chloride, 0.2 mM calcium chloride, and 50 
mM potassium hydrogen phosphate, pH 7.2 (Sigma-
Aldrich, St. Louis, MO, USA); (2) cocktail with 1 mM 
ethylene glycol tetraacetic acid; or (3) cocktail with 1 
mM ethylene glycol tetraacetic acid plus 1 mM L-NG-
monomethyl-L-arginine, monoacetate salt. NOS activity 
was quantified by measuring L-[14C]-citrulline with a 
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liquid-scintillation counter (Wallac 1410, Pharmacia LKB 
Biotechnology AB, Uppsala, Sweden), following removal 
of unreacted L-[14C]-arginine with Dowex 50W-X8 cation-
exchange resin (Sigma-Aldrich).
Measurement of nitric oxide production with 
nitrate plus nitrite assay
NO production was indirectly quantified by 
measuring the amount of nitrate plus nitrite in supernatants 
from tissue homogenates using a Nitrate/Nitrite 
Colorimetric Assay Kit (Cayman Chemicals, Ann Arbor, 
MI, USA) according to the manufacturer’s instructions 
[32, 33]. Briefly, 5-μL aliquots were injected into a Sievers 
Nitric Oxide Analyzer (NOA 280i; Sievers Instruments, 
Boulder, CO, USA) and pelleted by centrifugation with 
acetic acid as a reductant for nitrite and vanadium chloride 
and hydrogen chloride as reductants for nitrate and sodium 
iodide, respectively. Values were normalized for protein 
concentration as determined using the Bradford reagent. 
Nitrate plus nitrite level was expressed in units of μM 
based on tissue weight.
Statistical analysis
All values are provided as the mean ± standard 
error. Differences in the normalized mRNA and protein 
expression ratio, enzymatic activity, and nitrite plus 
nitrate concentration between the groups were assessed 
using one-way analysis of variance (ANOVA), followed 
by Bonferroni post hoc test. Statistical analyses were 
conducted using PASW Statistics for Windows (version 
18.0; Armonk, NY, USA). Statistical significance was 
defined as a P value less than 0.05.
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